)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
AB SCIENCE (AB) investor relations material
AB SCIENCE H1 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2025 earnings summary10 Oct, 2025
Executive summary
Advanced clinical development of masitinib in ALS, progressive MS, and Alzheimer's, with regulatory validation and new positive preclinical data in Alzheimer's.
AB8939 received orphan drug status from EMA for AML and secured new patents in Canada and the US for key molecules.
Multiple successful private placements raised €6.3M in the first half of 2025 to fund ongoing clinical programs.
Agreement reached to defer €3.7M in state-guaranteed loan repayments by two years, pending further negotiations on a €12M EIB loan.
U.S. patent granted for masitinib in sickle cell disease until 2040.
Financial highlights
Net revenue for H1 2025 was €515K, down from €560K in H1 2024 due to temporary sales decline of Masivet 50mg.
Operating loss reduced to €2.7M from €3.58M year-over-year, a 24% improvement.
Net loss increased to €5.18M from €4.47M, mainly due to higher financial charges.
Operating expenses fell 21.7%, with R&D and administrative costs both declining; administrative expenses dropped 31.1% to €893K.
Cash and equivalents at June 30, 2025, were €5.03M, down from €7.99M at year-end 2024.
Outlook and guidance
Focus remains on advancing masitinib and ALDH/Microtubule platforms, with continued investment in drug discovery and preclinical studies, subject to available funding.
Proceeds from capital increases will fund ongoing clinical development, especially for AB8939.
Ongoing search for partnerships to support late-stage clinical development and market authorization.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next AB SCIENCE earnings date
Status Update16 Oct, 2025
Next AB SCIENCE earnings date
Status Update16 Oct, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
AB Science is a biotechnology company specializing in the research, development, and commercialization of targeted therapies for serious diseases. The company focuses on small molecule drugs designed to address conditions in oncology, neurodegenerative disorders, and inflammatory diseases. The company is headquartered in Paris, France, and its shares are listed on the Euronext Paris.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage